Elicio Therapeutics

1 follower

‌

Elicio is committed to transforming the lives of patients and their families by re-engineering the body’s immune response to cancer.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Robert Connelly

CEO

Robert Connelly

Collapse

Peter C. DeMuth

Chief Scientific Officer

Megan Filoon

General Counsel, Secretary & Compliance Officer

Christopher Haqq

EVP, Head of R&D & CMO

Esther Welkowsky

SVP, Clinical Development

Thian Kheoh

SVP, Biometrics

Joy Seymour

VP & Head of Regulatory Affairs

Steve Flores

VP, Supply Chain

Kelli Arriola

Senior Manager, Clinical Sample Logistics

Michael Divecchia

SVP, Operations & Human Resources

Teams

+11

Finance and Administration

14 members

Leadership Team

5 members

Research and Development

8 members

Clinical Operations

5 members

Similar companies

Synthekine

3 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Neogene Therapeutics

2 followers

Apogee Therapeutics

1 follower

PMV Pharmaceuticals

1 follower

Slingshot Biosciences

1 follower

HydroPeptide LLC

3 followers

Priovant

2 followers

Gilead Sciences

129 followers

Biogen

115 followers

Explore companies